PHARMACYTE BIOTECH, INC. Proceeds from Loans
PHARMACYTE BIOTECH, INC. (PMCB) reported Proceeds from Loans of $0 for the 12-month period ending 2021-04-30, per its 10-K filed 2021-08-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLoans · last filed 2021-08-10
- PHARMACYTE BIOTECH, INC. proceeds from loans for the quarter ending 2021-04-30 was -$75.20K.
- PHARMACYTE BIOTECH, INC. proceeds from loans for the quarter ending 2021-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from loans for the quarter ending 2020-10-31 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from loans for the quarter ending 2020-07-31 was $75.20K.
- PHARMACYTE BIOTECH, INC. proceeds from loans for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- PHARMACYTE BIOTECH, INC. proceeds from loans for fiscal 2020 was $75.20K.
- PHARMACYTE BIOTECH, INC. proceeds from loans for fiscal 2019 was $0.00.
| Period end | Proceeds from Loans 3 month | Proceeds from Loans 6 month | Proceeds from Loans 9 month | Proceeds from Loans 12 month |
|---|---|---|---|---|
| 2021-04-30 | -$75.20K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | -$75.20K derived: sum of 2 quarters · filed 2021-08-10 | -$75.20K derived: sum of 3 quarters · filed 2021-08-10 | $0.00 10-K · filed 2021-08-10 |
| 2021-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $75.20K 10-Q · filed 2021-03-12 | |
| 2020-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-11 | $75.20K 10-Q · filed 2020-12-11 | ||
| 2020-07-31 | $75.20K 10-Q · filed 2020-09-11 | |||
| 2020-04-30 | $75.20K 10-K · filed 2020-08-13 | |||
| 2019-04-30 | $0.00 10-K · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |